MONTAGNANI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 6.508
AS - Asia 5.222
EU - Europa 3.917
AF - Africa 290
SA - Sud America 253
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 16.198
Nazione #
US - Stati Uniti d'America 6.400
SG - Singapore 1.592
VN - Vietnam 1.393
CN - Cina 1.146
GB - Regno Unito 898
IT - Italia 745
DE - Germania 467
SE - Svezia 461
HK - Hong Kong 338
FR - Francia 282
IN - India 228
RU - Federazione Russa 207
UA - Ucraina 207
IE - Irlanda 172
BR - Brasile 165
NL - Olanda 125
BD - Bangladesh 121
JP - Giappone 85
ZA - Sudafrica 84
EE - Estonia 67
CI - Costa d'Avorio 61
CA - Canada 60
KR - Corea 59
CH - Svizzera 54
TG - Togo 54
FI - Finlandia 52
BG - Bulgaria 44
TH - Thailandia 37
PH - Filippine 35
PL - Polonia 34
TR - Turchia 33
NG - Nigeria 30
JO - Giordania 27
MX - Messico 27
SC - Seychelles 27
AR - Argentina 25
EC - Ecuador 21
TW - Taiwan 20
IQ - Iraq 19
AT - Austria 18
BE - Belgio 18
ID - Indonesia 17
ES - Italia 16
MY - Malesia 14
GR - Grecia 13
IR - Iran 12
SA - Arabia Saudita 11
CO - Colombia 9
EG - Egitto 8
BO - Bolivia 7
CZ - Repubblica Ceca 7
PE - Perù 7
PK - Pakistan 7
MA - Marocco 6
PY - Paraguay 6
UZ - Uzbekistan 6
DK - Danimarca 5
HN - Honduras 5
LT - Lituania 5
TN - Tunisia 5
AO - Angola 4
AU - Australia 4
CL - Cile 4
LB - Libano 4
RO - Romania 4
UY - Uruguay 4
VE - Venezuela 4
DZ - Algeria 3
KW - Kuwait 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
BB - Barbados 2
CR - Costa Rica 2
ET - Etiopia 2
GH - Ghana 2
HU - Ungheria 2
JM - Giamaica 2
MK - Macedonia 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
VG - Isole Vergini Britanniche 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GL - Groenlandia 1
GN - Guinea 1
HR - Croazia 1
IL - Israele 1
KE - Kenya 1
LK - Sri Lanka 1
Totale 16.186
Città #
Singapore 1.124
Southend 782
Ashburn 637
Fairfield 635
Chandler 538
Santa Clara 326
San Jose 316
Hong Kong 314
Ho Chi Minh City 273
Hanoi 231
Houston 230
Dong Ket 219
Princeton 208
Seattle 202
Wilmington 196
Woodbridge 185
Bologna 171
Dublin 171
Cambridge 164
Beijing 153
Boardman 153
Ann Arbor 141
Jacksonville 127
New York 112
Hefei 106
Los Angeles 103
Lauterbourg 98
Dallas 90
Nanjing 85
Westminster 74
Council Bluffs 70
Tokyo 70
Buffalo 67
Padova 62
Abidjan 61
Berlin 60
Lomé 54
Milan 52
Saint Petersburg 49
Medford 48
Haiphong 46
Bern 42
Sofia 41
Helsinki 38
Jinan 37
Da Nang 35
Munich 34
São Paulo 33
Shenyang 32
Seoul 31
Dearborn 30
Guangzhou 30
Abeokuta 29
Changsha 28
Florence 28
Nanchang 28
Redondo Beach 28
San Diego 28
Amman 27
Hebei 27
Turin 26
Bremen 25
Chicago 25
Frankfurt am Main 24
Shanghai 24
Rome 23
Biên Hòa 22
London 22
Pune 22
Zhengzhou 22
Hải Dương 21
Redmond 21
Bangkok 19
Orem 19
San Francisco 19
Toronto 19
Des Moines 18
Mülheim 18
Phoenix 18
Falkenstein 17
Warsaw 17
Brussels 16
Jiaxing 16
Hangzhou 15
Johannesburg 15
Mahé 15
The Dalles 15
Amsterdam 14
Brooklyn 14
Tianjin 14
Xi'an 14
Mountain View 13
Redwood City 13
Taizhou 13
Atlanta 12
Can Tho 12
Falls Church 12
Norwalk 12
Shenzhen 12
Baghdad 11
Totale 10.108
Nome #
Antiinflammatory Effect of Phytosterols in Experimental Murine Colitis Model: Prevention, Induction, Remission Study 499
A new model for portal protein profile analysis in course of ileal intraluminal bile acid infusion using an in situ perfused rat intestine. 304
Attitudes of Crohn's Disease Patients: Infodemiology Case Study and Sentiment Analysis of Facebook and Twitter Posts 273
Chlamydia pneumoniae acute liver infection affects hepatic cholesterol and triglyceride metabolism in mice 272
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. 257
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension 255
Curcuma longa Extract Exerts a Myorelaxant Effect on the Ileum and Colon in a Mouse Experimental Colitis Model, Independent of the Anti-Inflammatory Effect 255
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 237
Acute Fitz-Hugh-Curtis Syndrome in a Man due to Gonococcal Infection 225
Curcuma longa L. as a therapeutic agent in intestinal motility disorders. 2: Safety profile in mouse. 225
The future of dual therapy for hepatitis C virus 223
Correlazione materno-fetale degli acidi biliari in corso di colestasi gravidica 221
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 218
High Doses of Ursodeoxycholic Acid Up-Regulate the Expression of Placental Breast Cancer Resistance Protein in Patients Affected by Intrahepatic Cholestasis of Pregnancy 217
Utility of Doppler-Ultrasound and Liver Elastography in the Evaluation of Patients with Suspected Pregnancy-Related Liver Disease 216
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. 216
Generation of a novel antibody probe to the Apical Sodium-Dependent Bile Acid Transporter that inhibits ileal bile acid absorption 212
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 212
Chlamydia pneumoniae replicates in Kupffer cells in mouse model of liver infection. 211
A Patient With Pancreas Divisum, Recurrent Acute Pancreatitis, and Homozygosity for the Cystic Fibrosis Transmembrane Regulator–Associated Protein 5T Allele 207
Production of reactive oxygen species and expression of inducible nitric oxide synthase in rat isolated Kupffer cells stimulated by Leptospira interrogans and Borrelia burgdorferi 202
Alisporivir for the treatment of chronic HCV 202
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 200
Dual-color bioluminescent assay using infected HepG2 cells sheds new light on Chlamydia pneumoniae and human cytomegalovirus effects on human cholesterol 7α-hydroxylase (CYP7A1) transcription. 190
Understanding Crohn's disease patients reaction to infliximab from facebook: A medical perspective 189
Severe immune thrombocytopenia after peg-interferonalpha2a, ribavirin and telaprevir treatment completion: A case report and systematic review of literature 189
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 182
Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: An emerging fungal agent. 180
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE 179
Sleisenger e Fordtran. Malattie gastrointestinali ed epatiche. Fisiopatologia, diagnosi e trattamento 178
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 176
Pharmacological modulation of MRP2 in primary biliary cirrhosis 173
Semisynthetic bile acid FXR and TGR5 agonists: Physicochemical properties, pharmacokinetics, and metabolism in the rats 169
Correlation between Indocyanine green retention test and esophageal varices among patients with hepatocellular carcinoma 168
PROTON PUMP INHIBITORS: RISKS OF LONG-TERM USE 165
Superior efficacy of twice a week administration of peginterferon alpha-2b plus ribavirin in obtaining SVR in HCV genotype 1 163
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 163
Indocyanine Green 15-min Retention test (ICG-r15) as a predictor of clinical decompensation in patients with compensated liver cirrhosis. 163
Indocyanine green clearance (ICG) as a predictor of 2-years clinical decompensation and mortality in patients with compensated liver cirrhosis 161
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 159
Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update 159
Indocyanine Green Clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis 159
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis 158
Can Liver Ultrasound Elastography Predict the Risk of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation? A Systematic Review and Meta-Analysis 157
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 157
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 156
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 156
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 155
Noninvasive diagnosis of portal hypertension and esophageal varices through the identification of liver blood flow markers 155
Indocyanine green clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis. 155
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 155
Approaches to the Diagnosis of Portal Hypertension: Non-Invasive or Invasive Tests? 152
Analysis of ileal sodium/bile acid cotransporter and related nuclear receptor genes in a family with multiple cases of idiopathic bile acid malabsorption 149
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients 149
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 148
Reduced biliary sterol output with no change in total faecal excretion in mice expressing a human apolipoprotein A-I variant 147
UDCA UP-REGULATES HUMAN PLACENTAL BCRP EXPRESSION: PRELIMINARY RESULTS 143
Indocyanine green retention test as a non-invasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis. 138
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 138
UDCA UP-REGULATES HUMAN PLACENTAL OATP-A EXPRESSION IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY 136
Bile acids: Physico-chemical properties, function and activity 136
Insulin resistance in viral hepatitis B and C and non virus related chronic hepatitis 134
New Developments in the Ultrasonography Diagnosis of Gallbladder Diseases 131
Hepatobiliary phospholipid transporter ABCB4, MDR3 gene variants in a large cohort of Italian women with intrahepatic cholestasis of pregnancy 130
High dose lamivudine in HBV-related cirrhotic patients with unsatisfactory response after adefovir add-on 130
Genetic polymorphisms of PPAR-alpha: allele frequency in gallstone patients. 129
Prognostic value of the albumin-bilirubin grade for the prediction of post-hepatectomy liver failure: A systematic review and meta-analysis 127
INFEZIONI E INFESTAZIONI DELL’APPARATO DIGERENTE (capitolo 56) 126
Malattie colestatiche del fegato. Rapporti tra fegato e gravidanza. In: Cirrosi epatica: epidemiologia, diagnosi e terapia. 126
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 126
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 126
The Diagnosis and Treatment of Acute Cholecystitis: A Comprehensive Narrative Review for a Practical Approach 125
Effects of cholesterol 7alpha-hydroxylase promoter polymorphisms on basal promoter activity and feedback regulation of bile acid synthesis 119
Intestinal microflora and motility in gallstones before and after cholecystectomy: any role for gallstone pathogenesis? 118
Insulin resistance in viral hepatitis B and C and non virus related chronic hepatitis 116
Infezioni, infestazioni, patologia gastroenterologica emergente dall’immigrazione (capitolo 56) 114
Violaceous Papules and Plaques on the Fingers during COVID-19: A Quiz 111
Treatment of acute hepatitis B with high dose lamivudine 107
Efficacy of ursodeoxycholic acid in association with α-interferon for chronic hepatitis C in α-interferon non-responder patients 106
Bile acid active and passive ileal transport in the rabbit: effect of luminal stirring 104
A comparison of the analytical performance of sodium dodecyl sulfate-polyacrylamide gel electrophoresis, electrospray and matrix-assisted laser desorption/ionization mass spectrometry in the study of the protein extract from bothrops jararaca snake venom 104
FISIOPATOLOGIA GASTRICA 104
Prevalence of different PPAR-alpha gene polymorphisms and haplotypes in gallstone patients. Dig Liv Dis 2005;Vol. 37 Suppl.1:S36. 102
Cholic acid metabolism in human fecal cultures during diet supplementation with Lactobacillus rhamnosus GG 102
Metabolic, nutritional and immunological parameters in healthy volunteers after inulin and saccharose feeding 100
MDR3 mutations in a large cohort of italian women with intrahepatic cholestasis of pregnancy 89
Long-term results with interferon therapy in chronic type B hepatitis: A prospective randomized trial 88
Gastric autoimmune disorders in patients with chronic hepatitis C before, during the after interferon-alpha therapy 87
Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid 87
Severe Precapillary Pulmonary Hypertension Due to Whipple Disease 83
Alcolismo e patologie alcool-correlate 83
Hepatic uptake and intestinal absorption of bile acids in the rabbit 82
Uptake and killing of Leptospira interrogans and Borrelia burgdorferi, spirochetes pathogenic to humans, by reticuloendothelial cells in perfused rat liver 81
Production of tumor necrosis factor alpha by Treponema pallidum, Borrelia burgdorferi s.l., and Leptospira interrogans in isolated rat Kupffer cells. 80
Uptake and killing of Lyme disease and relapsing fever borreliae in the perfused rat liver and by isolated Kupffer cells 80
Bile acid structure and intestinal absorption in the animal model 80
Phagocytosis of Treponema pallidum and reactive oxygen species production by isolated rat Kupffer cells 79
Repurposing 1,4-Dihydropyridine Scaffold: 4-Imidazo[2,1-b]thiazole-Derivatives from Calcium Entry Blockers to a New Approach for Gut Dysfunctional Motility 78
Relationship between structure and intestinal absorption of bile acids with a steroid or side-chain modification 78
GASTRIC PATHOPHYSIOLOGY 76
Totale 15.712
Categoria #
all - tutte 45.175
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.175


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021387 0 0 0 0 0 0 0 0 0 0 0 387
2021/20221.978 157 70 100 109 134 82 39 97 106 124 638 322
2022/20231.991 242 286 124 235 124 161 52 105 337 47 166 112
2023/2024678 34 94 33 119 50 178 30 30 36 26 23 25
2024/20252.195 83 350 183 148 426 89 128 47 46 172 75 448
2025/20265.627 454 391 469 288 767 307 587 124 1.083 440 510 207
Totale 16.472